CB Therapeutics, Inc.
Records under this name other than the patents CB Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,359,338 | Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,840,477 | Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,695,175 | Highly selective c-Met inhibitors as anticancer agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,981,994 | Anti PD-1 antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,111,300 | Anti PD-L1 Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 10,428,146 | Anti PD-1 antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,435,470 | ANTI-PD-L1 Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 11,560,429 | Anti PD-1 antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,827,707 | Anti PD-L1 Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 11,441,164 | Biosynthetic Production of Psilocybin and Related Intermediates in Recombinant Organisms Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |